IRCT2017061917139N2已完成3 期
The effects of resveratrol supplementation on hormonal, inflammatory and metabolic in women with PCOS.
EMRI0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 40 years（—）
- 性别
- Female
入选标准
- •PCOS diagnosis (according to Androgen Excess Society criteria); hyperandrogenism (hirsutism) / hyperandrogenemia (testosterone >70ng/dl) and/or oligomenorrhea (<8 spontaneous menses per year) and/or polycystic ovarian morphology on ultrasound
- •Women aged from 18 to 40 years old; Normal prolactin; normal thyroid function; 17-OH progesterone; No evidence of Androgenic hormone secretor tumors; Cushing's syndrome or acromegaly
- •Exclusion criteria:
- •Use of either oral contraceptives, steroids hormones or other medications that could modify the metabolism 3 months before the onset of the trial.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
已完成
2 期
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50
招募中
3 期
Resveratrol in multiple sclerosisMultiple sclerosisMultiple Sclerosis.IRCT20230315057731N1Ahvaz University of Medical Sciences60
已完成
3 期
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
已完成
3 期
Effect of resveratrol on serum irisin and adiponectin in patients With type 2 diabetesType 2 Diabetes Mellitus.non-insulin-dependent-diabetes-mellitusIRCT201601022394N19Vice chancellor for research, Iran University of Medical Sciences56